[{"address1": "1065 East Hillsdale Boulevard", "address2": "Suite 100", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 525 5535", "fax": "650 275 4254", "website": "https://www.ternspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.", "fullTimeEmployees": 59, "companyOfficers": [{"maxAge": 1, "name": "Ms. Amy L. Burroughs M.B.A.", "age": 55, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1007081, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melita Sun Jung", "age": 48, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 508886, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew W. Gengos", "age": 61, "title": "CFO & Head of Corporate Development", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caryn Gordon McDowell J.D.", "age": 55, "title": "Chief Legal Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Robin  Andrulevich", "age": 59, "title": "Chief People Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeffrey R. Jasper Ph.D.", "title": "Senior Vice President of Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emil T. Kuriakose M.D.", "age": 45, "title": "Chief Medical Officer", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Harris", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Debra  Sieminski", "title": "Senior Vice President of Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Kanter", "title": "Senior VP of CMC", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1767225600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 37.77, "open": 37.83, "dayLow": 35.0, "dayHigh": 38.3499, "regularMarketPreviousClose": 37.77, "regularMarketOpen": 37.83, "regularMarketDayLow": 35.0, "regularMarketDayHigh": 38.3499, "payoutRatio": 0.0, "beta": -0.281, "forwardPE": -29.295439, "volume": 3501111, "regularMarketVolume": 3501111, "averageVolume": 4044924, "averageVolume10days": 2114600, "averageDailyVolume10Day": 2114600, "bid": 30.62, "ask": 53.27, "bidSize": 2, "askSize": 2, "marketCap": 3859063040, "fiftyTwoWeekLow": 1.865, "fiftyTwoWeekHigh": 48.26, "allTimeHigh": 48.26, "allTimeLow": 1.45, "fiftyDayAverage": 30.9174, "twoHundredDayAverage": 11.620175, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2901424640, "profitMargins": 0.0, "floatShares": 66434739, "sharesOutstanding": 108767281, "sharesShort": 12767752, "sharesShortPriorMonth": 9515874, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.1174, "heldPercentInsiders": 0.00245, "heldPercentInstitutions": 0.82982004, "shortRatio": 2.41, "shortPercentOfFloat": 0.1174, "impliedSharesOutstanding": 108767281, "bookValue": 3.246, "priceToBook": 10.930375, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -94435000, "trailingEps": -1.02, "forwardEps": -1.21111, "enterpriseToEbitda": -26.783, "52WeekChange": 6.391667, "SandP52WeekChange": 0.19362879, "quoteType": "EQUITY", "currentPrice": 35.48, "targetHighPrice": 70.0, "targetLowPrice": 54.0, "targetMeanPrice": 58.125, "targetMedianPrice": 56.5, "recommendationMean": 1.2, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 295635008, "totalCashPerShare": 3.282, "ebitda": -108331000, "totalDebt": 1029000, "quickRatio": 19.213, "currentRatio": 19.516, "debtToEquity": 0.362, "returnOnAssets": -0.19944, "returnOnEquity": -0.29123, "freeCashflow": -51270876, "operatingCashflow": -77677000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TERN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -6.06302, "regularMarketPrice": 35.48, "corporateActions": [], "postMarketTime": 1768006764, "regularMarketTime": 1767992400, "exchange": "NMS", "messageBoardId": "finmb_558294166", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Terns Pharmaceuticals, Inc.", "longName": "Terns Pharmaceuticals, Inc.", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "postMarketChangePercent": -0.64825124, "postMarketPrice": 35.25, "postMarketChange": -0.22999954, "regularMarketChange": -2.29, "regularMarketDayRange": "35.0 - 38.3499", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 4044924, "fiftyTwoWeekLowChange": 33.614998, "fiftyTwoWeekLowChangePercent": 18.024128, "fiftyTwoWeekRange": "1.865 - 48.26", "fiftyTwoWeekHighChange": -12.779999, "fiftyTwoWeekHighChangePercent": -0.26481557, "fiftyTwoWeekChangePercent": 639.1667, "earningsTimestamp": 1762808400, "earningsTimestampStart": 1762808400, "earningsTimestampEnd": 1762808400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.02, "epsForward": -1.21111, "epsCurrentYear": -1.09444, "priceEpsCurrentYear": -32.418407, "fiftyDayAverageChange": 4.562599, "fiftyDayAverageChangePercent": 0.14757383, "twoHundredDayAverageChange": 23.859825, "twoHundredDayAverageChangePercent": 2.0533102, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-05", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "displayName": "Terns Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-01-10"}]